Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America
|
September 16, 1998
Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells
M J Marino, S T Rouse, A I Levey, et al.
Pharmacology & Therapeutics
|
May 5, 2001
Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders
S T Rouse, M J Marino, S R Bradley, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 11, 2001
Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata
M J Marino, M Wittmann, S R Bradley, et al.
Nature Neuroscience
|
April 9, 1999
Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems
S Alagarsamy, M J Marino, S T Rouse, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 25, 2000
Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata
S R Bradley, M J Marino, M Wittmann, et al.
Austin Journal of Clinical Ophthalmology
|
October 18, 2016
Histopathology of the Retina from a Three Year-Old Suspected to Have Joubert Syndrome
V L Bonilha, M E Rayborn, B A Bell, et al.
Neuropharmacology
|
May 31, 2011
The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents
P H Hutson, E N Finger, B C Magliaro, et al.
Schizophrenia Research
|
March 15, 2023
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers
M Cecchi, M Adachi, A Basile, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America
|
September 16, 1998
Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells
M J Marino, S T Rouse, A I Levey, et al.
Pharmacology & Therapeutics
|
May 5, 2001
Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders
S T Rouse, M J Marino, S R Bradley, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 11, 2001
Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata
M J Marino, M Wittmann, S R Bradley, et al.
Nature Neuroscience
|
April 9, 1999
Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems
S Alagarsamy, M J Marino, S T Rouse, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 25, 2000
Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata
S R Bradley, M J Marino, M Wittmann, et al.
Austin Journal of Clinical Ophthalmology
|
October 18, 2016
Histopathology of the Retina from a Three Year-Old Suspected to Have Joubert Syndrome
V L Bonilha, M E Rayborn, B A Bell, et al.
Neuropharmacology
|
May 31, 2011
The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents
P H Hutson, E N Finger, B C Magliaro, et al.
Schizophrenia Research
|
March 15, 2023
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers
M Cecchi, M Adachi, A Basile, et al.
Page
of 2